• Being male is a known risk factor for adverse outcomes in hospitalized COVID-19 patients. (llnl.gov)
  • A Lawrence Livermore National Laboratory (LLNL) team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient's disease state. (llnl.gov)
  • Using a machine learning algorithm on a dataset of electronic health records (EHRs) from more than 1,300 hospitalized COVID-19 patients with ProMedica - the largest health care system in northwestern Ohio and southeastern Michigan - the team classified patients into "moderate" or "severe" states and tracked disease trajectory as patients moved through different risk states during hospitalization. (llnl.gov)
  • Most significantly, while male patients were found to be more likely than female patients to have serious complications or die from COVID-19, when starting from the "severe" disease state, women were more likely than men to die of the disease. (llnl.gov)
  • By modeling the entire trajectory of hospitalized COVID-19 patients, the team showed "statistically significant differences" in the relative risk of disease progression, which they concluded should be taken into consideration when performing risk assessment among patients in hospitals. (llnl.gov)
  • A phase 3 study evaluating subcutaneous (SC) daratumumab plus pomalidomide found that daratumumab plus pomalidomide and dexamethasone (D-Pd) significantly reduced the risk of progression or death by 37% in patients with relapsed/refractory multiple myeloma (RRMM) who had received more than or equal to 1 prior line of therapy versus pomalidomide alone, according to data to be presented at the virtual American Society of Hematology (ASH) conference. (pharmacytimes.com)
  • The patients were randomized 1:1 to Pd ± daratumumab SC, and stratification was based on International Staging System disease stage and number of lines of prior therapy. (pharmacytimes.com)
  • All patients were treated until disease progression or unacceptable toxicity, with the primary endpoint being progression free survival (PFS). (pharmacytimes.com)
  • Further, 35% had high cytogenetic risk and 11% of patients had received 1PL. (pharmacytimes.com)
  • The study met its primary endpoint of improved PFS, with a hazard ratio of 0.63 representing a 37% reduction in the risk of progression or death in patients treated with D-Pd. (pharmacytimes.com)
  • Statin users were matched with chronic liver disease patients who did not need a statin. (realhealthmag.com)
  • See Tuberculosis: Diagnostic Imaging and Treatment Challenges , a Critical Images slideshow, to help determine the best approach for patients with this multisystemic disease. (medscape.com)
  • For patients with HIV infection, the risk of developing TB is 7-10% per year. (medscape.com)
  • Tuberculosis has been reported in patients treated for arthritis, inflammatory bowel disease, and other conditions with tumor necrosis factor (TNF)-alpha blockers/antagonists. (medscape.com)
  • AMSTERDAM - Patients with Parkinson's disease (PD) who are deep sleepers, defined as getting more slow-wave sleep, have slower progression of their disease compared to light sleepers, new research suggests. (medscape.com)
  • It indicates that higher slow-wave sleep predicts a slower progression of axial symptoms as well as gait and postural function in patients with Parkinson's disease. (medscape.com)
  • The mean disease duration of these patients was 5.2 years. (medscape.com)
  • Genetic testing may help identify patients with Barrett esophagus who are at highest risk for progression to esophageal adenocarcinoma. (medscape.com)
  • The investigators compared the frequency of pathogenic germline mutations in monoallelic cancer-predisposing genes between patients who had experienced progression and those who had not. (medscape.com)
  • Pathogenic germline mutations were identified in 9% of patients (59 of 640) with Barrett esophagus who had high-grade dysplasia or esophageal adenocarcinoma and in only 2.7% of those who did not experience progression. (medscape.com)
  • Progression to esophageal adenocarcinoma in patients with mutations was seen across the age spectrum, suggesting that additional triggers, such as having Barrett esophagus and experiencing environmental exposures, may be necessary for carcinogenesis. (medscape.com)
  • For patients who experience progression toward esophageal adenocarcinoma from Barrett esophagus, "performing genetic testing is probably warranted. (medscape.com)
  • Most (86.4%) of the 2,182 initial ARF patients did not experience disease progression by the end of 2015. (cdc.gov)
  • Progression was more rapid and ≈2 times more likely for indigenous Māori or Pacific Islander patients. (cdc.gov)
  • Because ALS is a non- notifiable condition in the US, Agency for Toxic Substances Disease Registry (ATSDR) uses a two- pronged approach to ascertaining ALS cases including (1) online registration by ALS patients via the web portal and (2) identifying ALS cases from large national databases (i.e. (cdc.gov)
  • The goal for primary care physicians is to identify patients who are at risk of developing problems from scoliosis, without overtesting or overreferring patients who are unlikely to have further problems. (aafp.org)
  • 12 Saliva-based genetic markers could be a useful adjunct in predicting which patients are at risk of scoliosis progression. (aafp.org)
  • 13 The screening itself carries little cost and negligible risk to the patient, but radiographs and referrals in youths who may be at low risk of disease progression can lead to significant expense and risk of harm to patients. (aafp.org)
  • Enhertu met the primary endpoint of progression-free survival in patients with HR-positive disease, reducing the risk of disease progression or death by 49% compared to chemotherapy. (drugdiscoverytrends.com)
  • The efficacy seen with Enhertu also reinforces the potential to establish a new standard of care for more than half of all patients with breast cancer currently categorized as having HER2-negative disease, but who actually have tumors with low HER2 expression. (drugdiscoverytrends.com)
  • Objectives To identify the predictive clinical characteristics and establish a prediction model for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). (bmj.com)
  • Results A total of 25/98 and 25/117 patients with SSc showed ILD progression in the derivation cohort and the validation cohort, respectively. (bmj.com)
  • Conclusions The evidence-based SPAR prediction model developed in our study might be helpful for the risk stratification of patients with mild SSc-ILD in clinical practice and cohort enrichment for future clinical trial design. (bmj.com)
  • Diffuse cutaneous subset, presence of antitopoisomerase-I antibodies, decreased baseline forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) were reported to be significantly associated with lung progression in patients with SSc, while positive anticentromere antibody (ACA) was protective. (bmj.com)
  • We included 1,066 probable AD patients from the Amsterdam Dementia Cohort (n = 290), Alzheimer's Disease Neuroimaging Initiative (n = 268), Dementia Competence Network (n = 226), and University of California, San Francisco (n = 282) with available follow-up data. (nih.gov)
  • AD patients with most prominently non-memory impairment show faster disease progression and higher risk of mortality than patients with most prominently memory impairment. (nih.gov)
  • Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients. (duke.edu)
  • BACKGROUND: Bevacizumab improves outcome for most recurrent glioblastoma patients, but the duration of benefit is limited and survival after initial bevacizumab progression is poor. (duke.edu)
  • Patients with cystic fibrosis who had cytomegalovirus had earlier times to lung transplant referral and reaching final stages of disease. (ajmc.com)
  • Researchers have identified a potential explanation for why some patients with cystic fibrosis experience faster disease progression, finding that patients with cytomegalovirus had earlier times to lung transplant referral and reaching final stages of disease. (ajmc.com)
  • The virus is most notable for causing visceral disease in immune-suppressed patients, as well as congenital infections. (ajmc.com)
  • We know that cystic fibrosis patients are more likely to develop lung infections, so it's possible that repeated cycles of activation of the virus exaggerates the damage to patients' lungs, contributing to faster disease progression. (ajmc.com)
  • The researchers also looked at patients' sex, body mass index, education, and presence of other infections and genetic traits, determining that cytomegalovirus was the most significant factor in disease progression. (ajmc.com)
  • USA: A new study published in The New England Journal of Medicine shows that patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer who had previously been treated with trastuzumab plus a taxane had a decreased risk of disease progression or death when given trastuzumab deruxtecan than when given trastuzumab emtansine. (medicaldialogues.in)
  • 1. At 12 months, 75.8% of 524 randomly assigned patients were alive without disease progression with trastuzumab deruxtecan and 34.1% with trastuzumab emtansine. (medicaldialogues.in)
  • Currently there is no strong evidence for recommending any oral adsorbents for preventing or delaying the progression for patients with CKD. (cochrane.org)
  • To quantify periodontal disease in rheumatoid arthritis (RA) patients and controls, and to correlate the degree of destruction from periodontal disease and from RA. (nih.gov)
  • Patients with longstanding active RA (mean +/- SD 13 +/- 8 years) who were receiving treatment with disease-modifying antirheumatic drugs (n = 46), corticosteroids (n = 38), or nonsteroidal antiinflammatory drugs (n = 43) had a higher rate of gingival bleeding (increased by 50%), greater probing depth (increased by 26%), greater attachment loss (increased by 173%), and higher number of missing teeth (increased by 29%) compared with controls. (nih.gov)
  • Patients with longstanding active RA have a substantially increased frequency of periodontal disease, including loss of teeth, compared with controls. (nih.gov)
  • Evidence Central , evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314086/all/Empagliflozin_slows_progression_of_renal_disease_in_very_high_risk_patients_with_T2DM. (unboundmedicine.com)
  • First described by Dr Tomisaku Kawasaki, it is a disease of unknown cause that affects the blood vessels usually in children aged less than 5 years (90-95% of Kawasaki disease patients are aged less than 10 years). (healthengine.com.au)
  • Patients with Kawasaki disease are also usually given aspirin to relieve symptoms and reduce the risk of formation of blood clots. (healthengine.com.au)
  • BUSINESS WIRE )--Positive results from the pivotal TROPION-Lung01 Phase III trial showed that datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant improvement for the primary endpoint of progression-free survival (PFS) compared to docetaxel, the current standard of care, in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) treated with at least one prior line of therapy. (businesswire.com)
  • The improvement in progression-free survival observed with datopotamab deruxtecan, particularly in patients with non-squamous tumors, and the improved tolerability of this antibody drug conjugate compared to docetaxel, represent a meaningful advance for patients with lung cancer. (businesswire.com)
  • The TROPION-Lung01 results demonstrate for the first time that an antibody drug conjugate can delay disease progression or death for longer than conventional chemotherapy in patients with advanced non-small cell lung cancer. (businesswire.com)
  • We evaluated whether lysyl oxidase-like 2 (LOXL2), which promotes cross-linking of collagen in pathological stroma, was detectable in serum from idiopathic pulmonary fibrosis (IPF) patients, and assessed its relationship with IPF disease progression. (ersjournals.com)
  • Patients from the ARTEMIS-IPF (n=69) and the Genomic and Proteomic Analysis of Disease Progression in IPF (GAP) (n=104) studies were analysed. (ersjournals.com)
  • Treatments such as empagliflozin (known as sodium-glucose cotransporter-2 (SGLT2) inhibitors) have been shown to benefit certain types of CKD patients, but it was uncertain whether the treatment would work for patients without diabetes and others at risk of kidney disease progression who had been underrepresented in previous clinical trials. (empakidney.org)
  • Will Herrington , Associate Professor at the Medical Research Council Population Health Research Unit at the University of Oxford, and co-Principal Investigator for EMPA-KIDNEY, said 'The majority of people with chronic kidney disease do not have diabetes and so it was important to find out whether empagliflozin would work for these patients and other types of patient who have been underrepresented in previous trials. (empakidney.org)
  • Thanks to the commitment of the trial participants and our collaborators around the world, we now know that empagliflozin reduces the risk of kidney disease progression or death from cardiovascular disease significantly in patients with, and without, diabetes. (empakidney.org)
  • A proof of principle study was undertaken to investigate the relationship between single nucleotide polymorphisms (SNPs) in literature based candidate cancer genes and the risk of nodal metastasis and clinical outcome in endometrioid endometrial cancer (EEC) patients. (wustl.edu)
  • Cancer is a major disease with millions of patients diagnosed each year with high mortality around the world. (nature.com)
  • Other doctors may use liver function tests to screen patients who are at risk for liver disease. (liverfoundation.org)
  • GESPIC cohort found that at the 10-year mark 12% of patients had no changes suggestive of radiographic disease. (consultantlive.com)
  • But I think it's important to note that even though these changes may not be occurring in some patients, like Tiffany, the disease burden is the same, the amount of pain, the amount of fatigue, and the amount of disability from physical dysfunction is in all the ways that we measure those things equivalent. (consultantlive.com)
  • As far as undifferentiated disease, just speaking on behalf of myself and others, it is also something in the rheumatology world where patients will come to us and say, "I have undifferentiated polyarthritis. (consultantlive.com)
  • At our nonprofit, we actually cover undifferentiated as one of our key primary diseases because there are so many patients who don't feel like they have a home. (consultantlive.com)
  • Introduction: Biomarkers to identify osteoarthritis (OA) patients at risk for disease progression are needed. (harvard.edu)
  • CHICAGO and RARITAN, NJ, May 30, 2015 - Data from the Phase 3 CLL3001 (HELIOS) trial demonstrated that the combination of ibrutinib (IMBRUVICA ® ) plus bendamustine and rituximab (BR) reduced the risk of progression or death by 80% and also significantly improved overall response rate (ORR) versus placebo plus BR in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL). (jnj.com)
  • Patients were randomized to receive either the combination of 420 mg ibrutinib orally once daily and six cycles of BR, or a matching regimen of placebo orally once daily and six cycles of BR, with ibrutinib or placebo continued until disease progression or unacceptable toxicity. (jnj.com)
  • In this work we present a multi-scale model of both aspects, coupling Finite Element (FE) and Agent Based (AB) techniques that we would like to use to predict the onset and progression of emphysema in patients. (upf.edu)
  • 2005). In addition, about half of patients with the closely related blood diseases, essential thrombocythemia (ET) and primary myelofibrosis (PMF), also carry the JAK21 m utation (Baxter et al. (cdc.gov)
  • Many patients with early Alzheimer's disease or other types of dementia are unaware that they have any problems. (medicinenet.com)
  • Here, Welsing et al ( Arthritis Rheum 50(7):2082, 2004 ) use GEE to investigate the longitudinal relationship of RA disease activity to radiographic damage in two different cohorts of RA patients. (hopkinsarthritis.org)
  • Patients are treated according to the discretion of their treating rheumatologist, but have regular assessments of disease activity (reported as DAS (disease activity scores) collected at baseline and every 3 months) and radiographs of hands and feet obtained at baseline and every three years. (hopkinsarthritis.org)
  • The baseline characteristics of patients enrolled in each of the cohorts was remarkably similar except that the COBRA group had higher disease activity at baseline (as required by the study protocol) and was followed for a longer period of time. (hopkinsarthritis.org)
  • For patients with early-stage (non-metastasized) HCC, a partial hepatectomy can offer a potential cure, provided the patient is a surgical candidate, based on performance status, comorbidities, and certain disease characteristics. (medscape.com)
  • In patients with chronic liver disease that would require major resection, consider preoperative portal vein embolization. (medscape.com)
  • Liver transplantation is generally considered a first choice for patients with early-stage HCC and moderate-severe cirrhosis (Child-Pugh class B and C), and to patients with unresectable disease. (medscape.com)
  • For patients with unresectable disease who are not surgical candidates because of their performance status, comorbidities, or failure to meet UNOS criteria, National Comprehensive Cancer Network (NCCN) guidelines recommend offering locoregional therapies before initiating systemic treatment. (medscape.com)
  • ritonavir tablets) is a prescription oral antiviral drug that reduces the risk of hospitalization and death for patients with mild-to-moderate COVID-19 who are at risk of disease progression and severe illness (1). (cdc.gov)
  • Evans M, Carrero JJ, Bellocco R, Barany P, Qureshi AR, Seeberger A, Jacobson SH, Hylander-Rössner B, Rotnitzky A, Sjölander A. Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients. (janusinfo.se)
  • The researchers followed the cohort for 14 years to see whether chronic liver disease progressed to cirrhosis, liver cancer, liver transplantation or liver-related death. (realhealthmag.com)
  • A prediction model for ILD progression was established in the derivation cohort and validated in the multinational validation cohort. (bmj.com)
  • Methods Prevalence of AMD-associated genetic risk variants, complement factor H (CFH) rs1061170, age-related maculopathy susceptibility 2 (ARMS2) rs10490924, component 3 (C3) rs2230199, complement factor B (CFB) rs641153 and superkiller viralicidic activity 2-like (SKIV2L) rs429608 and 4-year progression data in a population-representative cohort (The Irish Longitudinal study on Ageing (TILDA)) were assessed. (bmj.com)
  • Results Older age and the presence of CFH and ARMS2 risk alleles are two main risk factors associated with the prevalence of AMD in the TILDA cohort. (bmj.com)
  • Conclusions The prevalence of risk-associated genes and 4-year progression rates of AMD in this Ireland cohort are comparable with other Caucasian populations. (bmj.com)
  • For the progression cohort, the average age was 62 and average ΔJSW over 30 months was 0.68 mm. (harvard.edu)
  • Disease activity was measured as DAS28 at individual time points for COBRA, or as mean interval DAS or SD (standard deviation) of the mean interval DAS at each 3-month interval for the UMCN cohort. (hopkinsarthritis.org)
  • The time averaged radiographic progression in this cohort was 9.5 Sharp points per year. (hopkinsarthritis.org)
  • The time averaged radiographic progression in this cohort was 7.7 Sharp points per year, but the rate of radiographic progression tended to slightly slow with increasing disease duration. (hopkinsarthritis.org)
  • The Mediterranean diet consistently has been linked to lower risk of cancer, cardiovascular disease, and mortality. (ascopost.com)
  • Complications associated with MS, like infections, cardiovascular disease, and accidents, can cause the lifespan of someone with MS to be shorter than people who aren't living with MS. But treating these complications can greatly reduce the risk of a shortened lifespan. (healthline.com)
  • Carotid intima-media thickness (CIMT) is a marker of subclinical organ damage and predicts cardiovascular disease (CVD) events in the general population. (duke.edu)
  • Chronic kidney disease (CKD) is a worldwide public health problem which is at high increased risk of cardiovascular disease (CVD) and renal failure. (cochrane.org)
  • 4] Taubert K, Shulman S. Cardiovascular Disease: Kawasaki Disease. (healthengine.com.au)
  • The EMPA-KIDNEY clinical trial has demonstrated that empagliflozin, a treatment developed for diabetes, reduces the risk of kidney disease progression or death from cardiovascular disease by 28% in people with chronic kidney disease. (empakidney.org)
  • Chronic kidney disease (CKD) is often a progressive condition that can lead to the need for kidney dialysis or a transplant and increases the risk of cardiovascular disease. (empakidney.org)
  • Slowing chronic kidney disease progression and avoiding the need for dialysis or a kidney transplant is highly desirable due to the adverse effects on quality of life, and the increased risk of cardiovascular disease. (empakidney.org)
  • How does job stress contribute to cardiovascular disease, and what can be done to intervene? (cdc.gov)
  • Major secondary endpoints included overall response rate, rates of very good partial response or better and complete response or better, measurable residual disease‑negativity rate, overall survival, and safety. (pharmacytimes.com)
  • In addition, the drug met the primary endpoint of progression-free survival in the study, cutting the risk of disease progression or death by 49% compared to chemotherapy. (drugdiscoverytrends.com)
  • Time series analysis (Kalman filter) and survival analysis (Cox proportional hazards) were combined to produce a range of risk models. (hofstra.edu)
  • Objectives: The ability to stratify a patient's risk of metastasis and survival permits more refined care. (wustl.edu)
  • Progression-free survival (PFS) and overall survival (OS) was also evaluated. (wustl.edu)
  • The primary endpoint was IRC-assessed PFS and key secondary endpoints included ORR per IRC, overall survival (OS), rate of minimal residual disease negative remissions (MRD- remissions) and safety. (jnj.com)
  • Alzheimer's disease (AD) is a heterogeneous disorder. (nih.gov)
  • Researchers examined 152,459 microglial transcriptomes from 443 individuals, identifying 12 transcriptional states and their relationship to Alzheimer's disease. (news-medical.net)
  • Patterns in the Alzheimer's disease (AD) trajectory using Mendelian randomization (MR) and deep learning (DL). (news-medical.net)
  • Micro-ribonucleic acids (miRNAs) linked to cognition and Alzheimer's disease (AD). (news-medical.net)
  • Environmental toxins and Alzheimer's disease progression. (wellnessresources.com)
  • Alzheimer's disease (AD) is the most common form of dementia, which causes progressive memory loss and cognitive decline. (wellnessresources.com)
  • DETROIT - Neuroscience researchers at Wayne State University published a review article that confirms the usefulness of neurofilament light (NfL) blood levels to predict the likelihood and rate of progression of neurodegeneration in Alzheimer's disease. (eurekalert.org)
  • The cross-sectional literature indicates that blood NfL shows great promise as a monitoring biomarker to indicate the severity of neurodegeneration in Alzheimer's disease," Damoiseaux said. (eurekalert.org)
  • It could be especially useful in persons who show Alzheimer's pathology but are at present cognitively unimpaired, or in people who are highly likely to develop Alzheimer's disease due to having the APOE ε4 allele or higher Aβ load. (eurekalert.org)
  • Longitudinal studies also consistently found significant relationships between blood NfL and atrophy in brain regions vulnerable to Alzheimer's disease pathology. (eurekalert.org)
  • We found that an increase in blood NfL may precede Alzheimer's disease-related changes in cortical atrophy and may be elevated in the preclinical stages of Alzheimer's disease," Damoiseaux said. (eurekalert.org)
  • The work by Jung and Damoiseaux highlights that blood NfL is a useful prognostic marker for predicting the progression of neurodegeneration, as well as being a useful marker to assess the risk that a cognitively unimpaired person with a higher risk for Alzheimer's disease will show abnormal changes in brain structure and function. (eurekalert.org)
  • The review article, "The Potential of Blood Neurofilament Light as a Marker of Neurodegeneration in Alzheimer's disease," is published in the journal Brain , Aug. 4, 2023, doi.org/10.1093/brain/awad267 . (eurekalert.org)
  • Does dementia differ from Alzheimer's disease or are all forms of dementia Alzheimer's disease? (medicinenet.com)
  • If someone has memory loss associated with another condition, does that turn into Alzheimer's disease? (medicinenet.com)
  • A genetic factor has been implicated in the development and progression of scoliosis. (aafp.org)
  • Here, we will review how toxins affect brain physiology with a focus on mechanisms by which toxins may contribute to the development and progression of AD. (wellnessresources.com)
  • This review article focuses on the role of honey in modulating the development and progression of tumors or cancers. (mdpi.com)
  • Previous studies explored baseline predictors for lung progression and mortality in SSc-ILD. (bmj.com)
  • Furthermore, we investigated mortality risk associated with subtypes using Cox proportional hazard analyses. (nih.gov)
  • Furthermore, the non-memory subtype was associated with an increased risk of mortality compared with the memory subtype at trend level (HR = 1.36, CI = 1.00-1.85, p = 0.05). (nih.gov)
  • Information was collected on methods, participants, interventions and outcomes (incidence of end-stage kidney disease (ESKD), mortality, quality of life and adverse events). (cochrane.org)
  • Among all GAP subjects, higher sLOXL2 levels were associated with increased risk for mortality (HR 2.28, 95% CI 1.18-4.38). (ersjournals.com)
  • 3. Goal of the WHO strategy against CRDs is for Prevention and Control of to support Member States in their efforts to Chronic Respiratory Diseases reduce the toll of morbidity, disability and (CRDs)1 that was drafted after the expert consultation premature mortality related to chronic held in January 20012. (who.int)
  • This latter aspect is of particular interest because there are many unanswered questions regarding risks for disease progression, disability and mortality that can be addressed best in this study. (cdc.gov)
  • To be able to reduce morbidity and mortality, we first needed to quantify the rates of disease and to determine if any demographic or other risk factors were associated with developing cocci or with progression of the disease to its most severe forms. (cdc.gov)
  • Accounting for disease severity - in contrast to previous scientific literature examining only static risk factors - the method allowed the team to identify, as the disease progressed, when certain variables such as age and race, and comorbidities including diabetes and hypertension, led to more severe outcomes. (llnl.gov)
  • This disease-state perspective has not been shown before and indicates that where you are in your disease also determines your risk factors. (llnl.gov)
  • The vast majority of studies on COVID-19 risk factors ignore the temporal progression of the disease in their analysis," said LLNL co-author Braden Soper. (llnl.gov)
  • The models showed that, while being male, Black or having a medical comorbidity were all associated with an increased risk of progressing from moderate to severe disease states, the same factors resulted in a decreased risk of transitioning from a severe state to death. (llnl.gov)
  • A better understanding of NAFLD epidemiology and risk factors may facilitate ongoing prevention efforts aimed at reducing the quality of life burden, demand for a liver transplant, and risk of HCC all posed by the global rise in NAFLD. (termedia.pl)
  • After adjusting for factors known to increase risk of cancer getting worse over time-such as age, prostate-specific antigen (PSA), and tumor volume-men with a diet that contained more fruits, vegetables, legumes, cereals, and fish had a reduced risk of their prostate cancer growing or advancing to a point where many would consider active treatment. (ascopost.com)
  • Previous studies have identified genetic factors that determine the risk for developing MS , most of which were related to immune function, [but] this study shows that different genetic factors determine disease outcome, namely factors that affect the nervous system's ability to compensate for damage," notes Jeffrey Cohen, MD , a neurologist and director of the Cleveland Clinic's Mellen Center for MS Treatment . (everydayhealth.com)
  • These genetic factors could be used to predict outcome - or prognosis - to help determine how aggressive disease therapy needs to be," adds Dr. Cohen, who wasn't part of the Nature study. (everydayhealth.com)
  • Risk factors for the acquisition of tuberculosis (TB) are usually exogenous to the patient. (medscape.com)
  • The number of bacilli in the inoculum and the relative virulence of the organism are the major factors determining transmission of the disease. (medscape.com)
  • In fact, infection with human immunodeficiency virus (HIV) is one of the most significant risk factors for TB infection. (medscape.com)
  • The goals of the National Amyotrophic Lateral Sclerosis (ALS) Registry are to determine the incidence, prevalence, demographics, and risk factors for ALS in the United States (US). (cdc.gov)
  • Persons with ALS can also provide information about risk factors for ALS by completing one or more of the Registry's 17 online surveys. (cdc.gov)
  • To help determine your personal prognosis, it helps to understand the risk factors that may indicate a greater chance of developing a severe form of the condition. (healthline.com)
  • Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity. (duke.edu)
  • Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. (duke.edu)
  • Prevalence of AMD-associated genetic risk factors and rate of disease progression are unknown in Ireland. (bmj.com)
  • AD is a complex and multifactorial disease that involves several risk factors. (wellnessresources.com)
  • certain environmental factors have been reported to increase the risk of AD. (wellnessresources.com)
  • modeling for factors that increase or decrease disease susceptibilities in terms of race, gender, and conditions such as diabetes. (wikipedia.org)
  • Harris is co-inventor on an international patent application, Methods and systems for patient specific identification and assessment of ocular disease risk factors and treatment efficacy, He developed and generated data for two patents: "Treatment of Macular Edema" and "Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight. (wikipedia.org)
  • Here we provide evidence that intrinsic risk factors contribute only modestly (less than ~10-30% of lifetime risk) to cancer development. (nature.com)
  • First, we demonstrate that the correlation between stem-cell division and cancer risk does not distinguish between the effects of intrinsic and extrinsic factors. (nature.com)
  • Collectively, we conclude that cancer risk is heavily influenced by extrinsic factors. (nature.com)
  • Figure 1: Schematic showing how intrinsic processes and extrinsic factors relate to cancer risks through stem-cell division. (nature.com)
  • Figure 2: Correlation analysis of stem-cell division and cancer risk does not distinguish contribution of extrinsic versus intrinsic factors to cancer risk. (nature.com)
  • Song, M. & Giovannucci, E. L. Cancer risk: many factors contribute. (nature.com)
  • According to the National Cancer Institute (NCI) , race and sex are risk factors for developing multiple myeloma. (healthline.com)
  • Although the reason behind the worldwide rising incidence rates of multiple myeloma remains unclear, researchers theorize that it might be related to improvements in early recognition and diagnosis, as well as the rise of myeloma-related risk factors . (healthline.com)
  • The implication being that people living in developed countries may have more risk factors for multiple myeloma. (healthline.com)
  • But researchers have identified risk factors associated with the disease. (healthline.com)
  • It is possible that other mutations or predisposing factors are necessary for disease progression. (cdc.gov)
  • Although there is no way to prevent dementia, modifying the risk factors of high blood pressure , high cholesterol , alcohol intake, and keeping diabetes as well-controlled as possible, as well as exercising regularly can help. (medicinenet.com)
  • Factors that contribute to the progression of dementia haven't been fully identified. (medicinenet.com)
  • A combination of environmental and genetic factors plays a role in the disorder, and changes in multiple genes are thought to affect the risk of developing the condition. (medlineplus.gov)
  • Future public health risk for lead-related nephrotoxicity may be most significant in those rapidly developing countries where risk factors for CKD, including obesity and secondary HTN and diabetes mellitus, are increasing more rapidly than lead exposure is declining. (cdc.gov)
  • III, both to update national prevalence data from earlier surveys of disease, risk factors, and outcomes, and to provide a baseline population for conducting followup studies. (cdc.gov)
  • Contemporary worksite interventions to reduce CVD risk often combine individual behavior change with environmental and policy supports to address modifiable risk factors such as smoking, physical activity and nutrition. (cdc.gov)
  • Inmate risk factors for primary, severe, and disseminated cocci were determined. (cdc.gov)
  • Dr. West's research focuses on the exploration of LRRK2 and alpha-synuclein proteins as therapeutic targets for the amelioration of Parkinson's disease, novel biomarkers informative for disease mechanisms and therapeutic responses, and defining new cellular pathways important in neurodegeneration. (michaeljfox.org)
  • This study aimed to use mass spectrometry assays to identify representative peptides from several proteins in synovial fluid and peripheral blood, and assess their levels as biomarkers of OA progression. (harvard.edu)
  • We tested our implementation on a public emphysema image database and found that it can indeed simulate the evolution of clinical image biomarkers during disease progression. (upf.edu)
  • García-Bailo B, Da Costa LA, Arora P, Karmali M, El-Sohemy A, Badawi A. Plasma Vitamin D and Biomarkers of Cardiometabolic Disease Risk in Adult Canadians, 2007-2009. (cdc.gov)
  • The objectives of this study were to examine the association between vitamin D and traditional and novel biomarkers of cardiometabolic disease and to describe the extent of the month-to-month fluctuations of vitamin D in the Canadian population. (cdc.gov)
  • Novel biomarkers of risk, such as apolipoprotein (Apo) A1 and ApoB (2), and the inflammatory markers C-reactive protein (CRP), fibrinogen, and homocysteine (3-5), have been proposed. (cdc.gov)
  • However, the relationship between 25(OH)D and individual biomarkers of cardiometabolic disease has not been explored in the Canadian population, and whether it differs by sex is unknown. (cdc.gov)
  • We examined associations between cognitive subtype and disease progression, as measured with repeated Mini-Mental State Examination (MMSE) and Clinical Dementia Rating scale sum of boxes (CDR sob), using linear mixed models. (nih.gov)
  • Other types include dementia associated with Parkinson's disease or Huntington's disease. (medicinenet.com)
  • After adjustments for age and clinical characteristics, researchers saw a significant association between high baseline diet score and lower risk of cancer grade progression. (ascopost.com)
  • In clinical terms, the progression was much faster in the group of light sleepers compared to the group of deep sleepers," he said. (medscape.com)
  • Clinical trials addressing high-risk pediatric medical devices used in children. (news-medical.net)
  • BACKGROUND: As adoption of electronic health records continues to increase, there is an opportunity to incorporate clinical documentation as well as laboratory values and demographics into risk prediction modeling. (hofstra.edu)
  • OBJECTIVE: The authors develop a risk prediction model for chronic kidney disease (CKD) progression from stage III to stage IV that includes longitudinal data and features drawn from clinical documentation. (hofstra.edu)
  • Alon Harris is an American clinical scientist, professor of ophthalmology and Professor of Artificial Intelligence and Human Health, educator, inventor and researcher in the field of ocular blood flow and its relationship to diseases of the eye. (wikipedia.org)
  • Baseline serum LOXL2 (sLOXL2) levels were compared with baseline clinical and physiological surrogates of disease severity, and the association with IPF disease progression was assessed using a classification and regression tree (CART) method. (ersjournals.com)
  • It is characterized by different clinical phenotypes with different risk profiles. (upf.edu)
  • Prevention of radiographic progression of joint damage has thus become a goal of treatment, and an outcome for many clinical trials. (hopkinsarthritis.org)
  • The recent results of AIDS Clinical Trials Group Protocol 076, a controlled clinical trial sponsored by the National Institutes of Health in collaboration with the National Institute of Health and Medical Research and the National Agency of Research on AIDS in France, indicate that zidovudine administered to a selected group of HIV-infected women and their infants can reduce the risk for perinatal transmission of HIV by approximately two-thirds. (cdc.gov)
  • The recently reported results of AIDS Clinical Trials Group Protocol 076 demonstrated that ZDV administered to a selected group of HIV-infected pregnant women and their infants can reduce the risk for perinatal HIV transmission by approximately two-thirds. (cdc.gov)
  • Results were expressed as risk ratios (RR) for dichotomous outcomes or as mean differences (MD) for continuous data with 95% confidence intervals (CI). (cochrane.org)
  • Although not statistically significant, the observed results are consistent with other trials which have shown clear statistical reductions in the risk of these outcomes. (empakidney.org)
  • Staying up to date with COVID-19 vaccination lowers the risk of getting COVID-19 and helps prevent serious outcomes of COVID-19, such as severe illness, hospitalization, and death. (cdc.gov)
  • Arthritis News : What is the Relationship of RA Disease Activity to Radiographic Progression of Joint Damage? (hopkinsarthritis.org)
  • These questions are not readily answered by conventional statistical analysis methods which use time-averaged estimates of radiographic progression and disease activity over a study interval. (hopkinsarthritis.org)
  • Time-averaged estimates do not take into account the variability of disease within an individual patient, and also assume a linear rate of radiographic progression. (hopkinsarthritis.org)
  • Regression models using GEE were constructed to evaluate trends in radiographic progression. (hopkinsarthritis.org)
  • Then baseline variables thought to be predictive of radiographic progression (age at baseline, sex, rheumatoid factor, baseline Sharp score, baseline DAS score) were entered into the model. (hopkinsarthritis.org)
  • Using GEE, the rate of radiographic progression was found to slow slightly with increasing disease duration. (hopkinsarthritis.org)
  • Of the baseline variables considered, only RF positivity and Sharp score at baseline were positive correlated with radiographic progression. (hopkinsarthritis.org)
  • However, the mean interval DAS, and SD of the mean interval DAS, were also positively correlated with radiographic progression even after adjusting for RF positivity and baseline Sharp scores. (hopkinsarthritis.org)
  • Thus, periods of higher disease activity (mean interval DAS) or fluctuating disease activity (SD of mean interval DAS) were associated with more radiographic progression. (hopkinsarthritis.org)
  • 10% lower risk of progression. (ascopost.com)
  • Those with ≥1 result prior and received recommended therapy had a longer median PFS and lower risk of progression. (ispor.org)
  • Centers for Disease Control and Prevention. (cdc.gov)
  • I'm Commander Ibad Khan and I'm representing the Clinician Outreach and Communication Activity COCA with the Emergency Risk Communication Branch at the Centers for Disease Control and Prevention. (cdc.gov)
  • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. (cdc.gov)
  • The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to update healthcare providers, public health departments, and the public on the potential for recurrence of COVID-19 or "COVID-19 rebound. (cdc.gov)
  • Since this disease is contracted by inhaling fungal spores that are carried invisibly in the air, and since the disease is not spread person-to-person, the public health community, including the Centers for Disease Control and Prevention, has been able to offer very little guidance on preventing cocci. (cdc.gov)
  • The alternate hypothesis will also be tested, that LRRK2 activity changes over time, potentially responsive to disease status and severity. (michaeljfox.org)
  • However, new analysis reveals that when modeling the entire disease trajectory, the degree to which being male is a risk factor depends on the underlying disease severity of the patient. (llnl.gov)
  • Based on their findings, "the genetics of disease severity now suggest that the CNS should be the target of [any] new class of therapeutics," he says. (everydayhealth.com)
  • The severity of the disease varies widely from person to person. (healthline.com)
  • She has worked extensively on several research projects based on molecular spectroscopic analysis of proteins and nucleic acids and radiological assessment of morphological alterations correlated with disease severity in potentially malignant conditions. (news-medical.net)
  • However, these approaches do not address the underlying sources of workplace stress that contribute to the progression of disease. (cdc.gov)
  • In a study examining the effect of a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease. (ascopost.com)
  • To report baseline visual fields in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) study. (duke.edu)
  • 75% of those who progressed from early to late disease had soft drusen and hyperpigmentation at baseline. (bmj.com)
  • COBRA enrollees had regular assessments of disease activity (DAS28 collected at baseline, and at weeks 16, 28, 40, 56, and annually after the double-blind portion of the study concluded) and radiographs of hands and feet at baseline and every 6 months during the double-blind portion of the study, and every year thereafter. (hopkinsarthritis.org)
  • Scientists have discovered a genetic variant that appears to predict faster symptom progression in people with multiple sclerosis. (everydayhealth.com)
  • For the first time ever, researchers have identified a genetic variant that may help predict faster symptom progression - and thus, more rapid declines in mobility and independence - in people with multiple sclerosis (MS) . (everydayhealth.com)
  • Researchers attributed the counterintuitive results to the existing prevalence of static models for risk stratification. (llnl.gov)
  • Chronic Obstructive Pulmonary Disease (COPD) is a disabling respiratory pathology, with a high prevalence and a significant economic and social cost. (upf.edu)
  • The trial is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and conducted by the NIAID-funded Immune Tolerance Network. (mlo-online.com)
  • Cytomegalovirus is normally dormant in people who have it, but it can become active again and spread more quickly after infection with other bacteria,' Michael Parkins, associate professor of medicine, Microbiology and Infectious Diseases, University of Calgary, Canada, said in a statement . (ajmc.com)
  • Dr. John Farley, the Director of the Office of Infectious Diseases at the Office of New Drugs at the Center for Drug Research at the US Food and Drug Administration. (cdc.gov)
  • However as control of these infectious diseases is hopefully achieved they will be replaced by a growing population of those with long term respiratory conditions which in many cases reflect current lifestyle changes. (who.int)
  • Sarah Gregory] I'm Sarah Gregory, for Emerging Infectious Diseases . (cdc.gov)
  • Of these, 45% had NAFLD, 22% had alcohol-related liver disease, 18% had viral hepatitis and 15% had autoimmune hepatitis. (realhealthmag.com)
  • But people with viral hepatitis and autoimmune hepatitis did not see a significant reduction in risk. (realhealthmag.com)
  • Systemic sclerosis (SSc) is a heterogeneous autoimmune disease, characterised by vascular damage, inflammation and fibrosis of skin and various visceral organs. (bmj.com)
  • I'm going to couch that a little bit by telling you that rheumatology is still not an exact science and, not infrequently, many of us do use terms such as overlap autoimmune disease or undifferentiated , a term that Atul used previously. (consultantlive.com)
  • Autoimmune Addison disease affects the function of the adrenal glands, which are small hormone-producing glands located on top of each kidney. (medlineplus.gov)
  • The signs and symptoms of autoimmune Addison disease can begin at any time, although they most commonly begin between ages 30 and 50. (medlineplus.gov)
  • A characteristic feature of autoimmune Addison disease is abnormally dark areas of skin (hyperpigmentation), especially in regions that experience a lot of friction, such as the armpits, elbows, knuckles, and palm creases. (medlineplus.gov)
  • Other signs and symptoms of autoimmune Addison disease include low levels of sugar (hypoglycemia) and sodium (hyponatremia) and high levels of potassium (hyperkalemia) in the blood. (medlineplus.gov)
  • Autoimmune Addison disease can lead to a life-threatening adrenal crisis, characterized by vomiting, abdominal pain, back or leg cramps, and severe hypotension leading to shock. (medlineplus.gov)
  • Individuals with autoimmune Addison disease or their family members can have another autoimmune disorder, most commonly autoimmune thyroid disease or type 1 diabetes . (medlineplus.gov)
  • The cause of autoimmune Addison disease is complex and not completely understood. (medlineplus.gov)
  • The genes that have been associated with autoimmune Addison disease participate in the body's immune response. (medlineplus.gov)
  • The most well-known risk factor for autoimmune Addison disease is a variant of the HLA-DRB1 gene called HLA-DRB1*04:04 . (medlineplus.gov)
  • This and other disease-associated HLA gene variants likely contribute to an inappropriate immune response that leads to autoimmune Addison disease, although the mechanism is unknown. (medlineplus.gov)
  • In autoimmune Addison disease, however, an immune response is triggered by a normal adrenal gland protein, typically a protein called 21-hydroxylase. (medlineplus.gov)
  • A shortage of adrenal hormones (adrenal insufficiency) disrupts several normal functions in the body, leading to hypoglycemia, hyponatremia, hypotension, muscle cramps, skin hyperpigmentation and other features of autoimmune Addison disease. (medlineplus.gov)
  • Rarely, Addison disease is not caused by an autoimmune reaction. (medlineplus.gov)
  • Membranous nephropathy is rare in children and, when it occurs, is usually due to hepatitis B virus infection, SLE, or autoimmune thyroid disease. (msdmanuals.com)
  • They also looked at an index of seven UPDRS 3 symptoms (the UPDRS progression factor), which, according to Dr Schreiner, best indicates PD progression. (medscape.com)
  • Over a mean observation time of about 5 years, the levodopa equivalent dose was significantly increased, as were the UPDRS 3 score and the "progression factor. (medscape.com)
  • INTRODUCTION: Obesity is a major risk factor for the development of osteoarthritis in both weight-bearing and nonweight-bearing joints. (duke.edu)
  • Chronic exposure to toxins has been seen as an environmental factor that may increase the risk of developing a neurodegenerative disease such as AD. (wellnessresources.com)
  • Sleep Disturbance as Potential Risk and Progression Factor for Parkinson's Disease. (ox.ac.uk)
  • Low socioeconomic status is a risk factor for both lead exposure and diseases that increase susceptibility. (cdc.gov)
  • Clinicians, however, usually do not consider occupational stress as a preventable risk factor for CVD. (cdc.gov)
  • Diabetes was a risk factor for severe pulmonary cocci, and African American ethnicity a risk factor for disseminated disease. (cdc.gov)
  • 4-6 However, due to their known toxicity, overall mild to moderate and short-lasting effects, CYC and MMF are generally administered only to selected cases with risk for ILD deterioration. (bmj.com)
  • Statins have been shown to reduce the risk for liver cancer recurrence after liver transplantation, but their impact on other liver conditions is less well-established. (realhealthmag.com)
  • Men with prostate cancer are motivated to find a way to impact the advancement of their disease and improve their quality of life," said Justin Gregg, MD , Assistant Professor of Urology at The University of Texas MD Anderson Cancer Center and lead author of the study. (ascopost.com)
  • A Mediterranean diet is noninvasive, good for overall health and, as shown by this study, has the potential to effect the progression of their cancer. (ascopost.com)
  • These findings are significant, as the rate of prostate cancer diagnosis is more than 50% higher in Black men, who also have a higher risk of prostate cancer death and disease progression. (ascopost.com)
  • Future research is needed to see if the same effects are seen for larger and more diverse patient groups and men with higher-risk prostate cancer. (ascopost.com)
  • Steroid therapy, cancer chemotherapy, and hematologic malignancies increase the risk of TB. (medscape.com)
  • Cite this: Mutations May Predict Progression From Barrett's to Cancer - Medscape - Aug 10, 2023. (medscape.com)
  • Does Anti-Reflux Surgery Cut Esophageal Cancer Risk in Barrett Esophagus? (medscape.com)
  • Those with MS tend to die from many of the same conditions as people who don't have the condition, like cancer and heart disease . (healthline.com)
  • Recent research has highlighted a strong correlation between tissue-specific cancer risk and the lifetime number of tissue-specific stem-cell divisions. (nature.com)
  • Whether such correlation implies a high unavoidable intrinsic cancer risk has become a key public health debate with the dissemination of the 'bad luck' hypothesis. (nature.com)
  • Finally, we show that the rates of endogenous mutation accumulation by intrinsic processes are not sufficient to account for the observed cancer risks. (nature.com)
  • playing a positive role in colorectal cancer risk? (nature.com)
  • Figure 4: Theoretical lifetime intrinsic risks (tLIR) for cancers based on different number of hits ( k ) required for cancer onset. (nature.com)
  • Tomasetti, C. & Vogelstein, B. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. (nature.com)
  • Cancer risk: role of environment. (nature.com)
  • Cancer risk: role of chance overstated. (nature.com)
  • Potter, J. D. & Prentice, R. L. Cancer risk: tumors excluded. (nature.com)
  • O'Callaghan, M. Cancer risk: accuracy of literature. (nature.com)
  • Tomasetti, C. & Vogelstein, B. Cancer risk: accuracy of literature - response. (nature.com)
  • Altenberg, L. Statistical problems in a paper on variation in cancer risk among tissues, and new discoveries. (nature.com)
  • Conclusion: SNPs in cancer genes including rs2159359 SNP in NME1 and rs13222385 in EGFR may stratify risk in EEC and are prioritized for further investigation. (wustl.edu)
  • In an interesting study, it was suggested that intake of tomato, tomato based products or lycopene can be associated with lower risk of cancer 8 . (nature.com)
  • A better understanding of these mechanisms may help contribute towards the development of an effective strategy to slow the progression of AD. (wellnessresources.com)
  • During these examinations, investigators obtained Unified Parkinson's Disease Rating Scale (UPDRS) scores. (medscape.com)
  • Sleep disturbances are common and a major source of disability in Parkinson's disease (PD). (ox.ac.uk)
  • He currently directs the Duke Center for Neurodegeneration and Neurotherapeutic Research, serves on the NINDS Parkinson's Disease Biomarker Program steering committee, the Executive Scientific Advisory Board at The Michael J. Fox Foundation, the NIH NSD-B study section, and is a board-reviewing editor for eLife. (michaeljfox.org)
  • The genetic variant may also help explain why people with the condition experience progression differently, with some needing a wheelchair within 10 years of diagnosis, while others continue to remain able to walk without assistive devices, according to Baranzini. (everydayhealth.com)
  • The association we found does not necessarily mean that cytomegalovirus directly causes more rapid disease progression-further studies are needed before such a bold statement could be made," Parkins said "However, our findings provide the first indication that this virus may have an impact on progression of cystic fibrosis, potentially leading to earlier transplant referral and even death. (ajmc.com)
  • The discovery is significant, Baranzini and his colleagues note, because while there are treatments that help manage flares in relapsing-remitting MS, currently available therapies - namely, immune system modulators, or immunomodulators - can only slow down, but not stop, progression, or a long-term worsening of symptoms. (everydayhealth.com)
  • Keeping B cells outside of the brain by blocking their migration but retaining them in the blood could reduce MS symptoms and progression - without the infectious side effects because they are not depleted from the rest of the body. (medicalnewstoday.com)
  • A small number of children persistent arthritis or heart symptoms due to the disease. (healthengine.com.au)
  • We hypothesize that the higher LRRK2 activity will predict the higher risk for developing PD in LRRK2 mutation carriers, and worse disease phenotypes will correlate with LRRK2 activity levels that we predict are stable over time. (michaeljfox.org)
  • We linked ARF progression outcome data (recurrent hospitalization for ARF, hospitalization for rheumatic heart disease [RHD], and death from circulatory causes) for 1989-2015. (cdc.gov)
  • Linked to obesity and diabetes, fatty liver disease is increasingly recognized as a metabolic disorder. (realhealthmag.com)
  • The researchers also examined the effect of diabetes and statin use and found a similar risk reduction in these patient groups. (ascopost.com)
  • The research was supported by the Elsa U. Pardee Foundation, the American College of Gastroenterology, and the National Institute of Diabetes and Digestive and Kidney Diseases. (medscape.com)
  • Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. (duke.edu)
  • Charcot neuroarthropathy (CN) is a rare but serious sequela of diabetes and other diseases that cause peripheral neuropathy. (duke.edu)
  • Circadian misalignment reduces glucose tolerance, providing a mechanism to help explain the increased diabetes risk in shift workers. (greenmedinfo.com)
  • Lower SpO 2 after 6 min walk test (6MWT) and arthritis ever were identified as independent predictors for ILD progression in both cohorts. (bmj.com)
  • Genetic association as indicators of disease and as predictors of progression were assessed by multinomial logistic regression. (bmj.com)
  • HIVandHepatitis.com coverage of the 2017 American Association for the Study of Liver Diseases (AASLD) Liver Meeting in Washington, DC, October 20-24, 2017. (hivandhepatitis.com)
  • The major diseases to be identified are rheumatoid arthritis, osteoarthritis and gout. (cdc.gov)
  • Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease of the lungs involving airway epithelial cell damage, fibroblast activation and proliferation, and excessive deposition of collagen and other extracellular matrix (ECM) components [ 1 ]. (ersjournals.com)
  • However, there are certain drugs, commonly known as anti-B cell drugs, which help moderate attacks and delay the progression of disability. (medicalnewstoday.com)
  • These findings may have public health implications when recommending vitamin D for the prevention of cardiometabolic disease and related conditions. (cdc.gov)
  • But since the disease varies so much from person to person, it can be difficult for doctors to predict whether their condition will worsen or improve. (healthline.com)
  • However], genetic information significantly de-risks drug development. (everydayhealth.com)
  • Inmates of African American ethnicity who were 40 years of age and older were at significantly higher risk for primary cocci than their white counterparts. (cdc.gov)
  • 1 Interstitial lung disease associated with SSc (SSc-ILD) is a common complication and leading cause of death in SSc. (bmj.com)
  • Also, Trastuzumab deruxtecan treatment was linked to interstitial lung disease and pneumonitis. (medicaldialogues.in)
  • These modifications of ECM composition and organisation alter the biomechanical properties of the lung parenchyma and increase local tension, which is critical in IPF disease pathogenesis [ 5 ]. (ersjournals.com)
  • Fibrosis and diffuse interstitial lung disease. (who.int)
  • However, emphysema onset and progression are influenced by a complex interaction between the immune system and the mechanical properties of biological tissue. (upf.edu)
  • JAK2 positive individuals should have periodic evaluations to monitor for possible disease onset or progression. (cdc.gov)
  • 800 pg·mL −1 ) was associated with increased risk for disease progression (hazard ratio (HR) 5.41, 95% CI 1.65-17.73). (ersjournals.com)
  • The G allele in rs7795743 in EGFR had an OR for metastasis of 0.68 (p-value = 0.02) and hazard ratio (HR) for progression of 0.66 (p-value = 0.004). (wustl.edu)
  • Evidence supporting the multiple mechanisms by which job stress contributes to cardiovascular diseases (and other chronic health conditions) comes from a vast body of international scientific literature that includes epidemiologic studies, patho-physiological studies of animals and humans, and behavioral studies. (cdc.gov)
  • Mutations in these genes occurred, respectively, in 1.6% and 1.25% of participants who experienced progression to esophageal adenocarcinoma. (medscape.com)
  • The findings suggest that certain "mutations facilitate the progression of Barrett's esophagus to adenocarcinoma," the authors said. (medscape.com)
  • Conclusions: Our results suggest that when combined, levels of peptides representative of clusterin and lubricin in plasma are as predictive of OA progression as age. (harvard.edu)
  • A national patient register could help monitor, prevent, and reduce ARF progression. (cdc.gov)
  • On June 6, 1994, the U.S. Public Health Service convened a workshop in Bethesda, Maryland, to develop recommendations for the use of zidovudine to reduce the risk for perinatal transmission of human immunodeficiency virus (HIV). (cdc.gov)
  • These recommendations update the interim guidelines (1) developed by the U.S. Public Health Service for the use of zidovudine (ZDV) to reduce the risk for perinatal transmission of human immunodeficiency virus (HIV) infection. (cdc.gov)
  • Our previous study found a convenient way to detect mutant-associated LRRK2 activity in small vesicles (exosomes) isolated from urine, and discovered the potential of this as a non-invasive biomarker to help with disease prediction. (michaeljfox.org)
  • Our study provides a unique modeling-based approach to understanding how patient demographics and medical comorbidities can present different risk profiles depending on the underlying disease state. (llnl.gov)
  • The study was limited by the low number of events in these men with mostly low-risk disease monitored at MD Anderson. (ascopost.com)
  • Now, a new study by the University of Montreal Hospital Research Centre (CRCHUM) in Canada has shown a way of decelerating the progression of MS and possibly overcoming some of the health risks associated with traditional B cell treatments. (medicalnewstoday.com)
  • The study showed that blocking ALCAM in mice lessens the flow of B cells to the brain and slows the progression of MS. (medicalnewstoday.com)
  • These promising results support the need for future studies to further evaluate the benefits and risks of HDIT/HCT and directly compare this treatment strategy to current MS therapies," says NIAID Director Anthony S. Fauci, MD. "If the findings from this study are confirmed, HDIT/HCT may become a potential therapeutic option for people with this often-debilitating disease, particularly those who have not been helped by standard treatments. (mlo-online.com)
  • Javier Cortés and THE team conducted this study with the objective to compare the disease progression when treated with trastuzumab deruxtecan and trastuzumab emtansine. (medicaldialogues.in)
  • In conclusion, the findings of this study shows the overall efficiency of trastuzumab deruxtecan rather than trastuzumab emtansine with respect to death or risk of disease progression. (medicaldialogues.in)
  • A 2020 study found that rates are rising most noticeably in Australia, New Zealand, Western Europe, and the United States, where the disease is most common. (healthline.com)
  • Inadequate vitamin D status has been associated with elevated cardiometabolic disease risk, although results are inconsistent, as evidenced by recent meta-analyses pooling multiple study populations (6-8). (cdc.gov)
  • The possibility that the effects of vitamin D on cardiometabolic disease differ by sex warrants further study. (cdc.gov)
  • These diseases represented the second most common cause of comorbidity in the Framingham Study. (cdc.gov)
  • The authors of this study are currently employed by the federal Receiver under the California Correctional Health Care Services, or CCHCS, and we are part of the Public Health Branch that is in charge of preventing diseases and conditions of public health importance. (cdc.gov)
  • We then used the study findings to ensure that the most vulnerable of our inmates were not housed at the two prisons with the highest rates of disease. (cdc.gov)
  • Chaitanya Thandra K, Barsouk A, Saginala K, Sukumar Aluru J, Rawla P, Barsouk A. Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression. (termedia.pl)
  • Non-alcoholic fatty liver disease (NAFLD) has grown in incidence to become the most common chronic liver disease worldwide [1] and is projected to surpass alcoholic liver disease as the leading cause of liver transplantation in the United States by 2030 [2]. (termedia.pl)
  • Levels of aminotransferase enzymes (alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) have also been used with varying degrees of success as a screening tool for liver disease. (termedia.pl)
  • Ultrasonography has become the standard modality for screening for moderate to severe fatty liver disease. (termedia.pl)
  • People who used cholesterol-lowering medications had a 40% lower risk for liver disease progression. (realhealthmag.com)
  • Non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), are responsible for a growing burden of liver disease worldwide. (realhealthmag.com)
  • Rajani Sharma, MD, of Columbia University Irving Medical Center, and colleagues explored the potential effect of statins on liver disease progression. (realhealthmag.com)
  • The analysis included 3,862 statin users with chronic liver disease who had not yet developed cirrhosis. (realhealthmag.com)
  • During this period, 6% of statin users progressed to advanced stages of liver disease compared with 7% of those who did not take statins. (realhealthmag.com)
  • Overall, people taking statins had a 40% lower risk for liver disease progression compared with those who did not use these medications. (realhealthmag.com)
  • The risk of progressing to severe liver disease was 60% lower for people with alcohol-related liver disease and 32% lower for those with NAFLD. (realhealthmag.com)
  • Among individuals with non-cirrhotic chronic liver disease, incident statin use was linked to lower rates of severe liver disease, suggesting a potential disease-modifying role," wrote the researchers. (realhealthmag.com)
  • They added that more research is needed to establish how statins appear to slow progression of liver disease. (realhealthmag.com)
  • Doctors also use them to monitor a person's liver disease and to check if treatment is working. (liverfoundation.org)
  • Kidney disease progression or death from cardiovascular causes occurred in 432 participants (13.1%) in the empagliflozin group and 550 participants (16.9%) in the placebo group during a median follow-up period of two years. (empakidney.org)
  • No new side effects of empagliflozin were identified, and the benefits of the treatment outweighed the risks. (empakidney.org)
  • Furthermore, this variant affects genes that are active in the CNS, a clear contrast to variants that confer risk, which overwhelmingly affect the immune system. (everydayhealth.com)
  • Carriers of CFH risk allele showed a strong association for disease progression. (bmj.com)
  • Heterozygosity for ARMS2 risk allele predicted progression to late AMD. (bmj.com)
  • From the moderate disease state, men are more likely to transition to a more severe disease state. (llnl.gov)
  • However, if you are in the severe disease state, surprisingly, women are more likely to die than men. (llnl.gov)
  • Males and females are about equally likely to have minor scoliosis of approximately 10 degrees, but females are five to 10 times more likely to progress to more severe disease, possibly needing treatment. (aafp.org)
  • Prodromal presence of RBD is associated with a more severe motor and non-motor PD subtype implying a significant disease-modifying effect of this parasomnia. (ox.ac.uk)
  • there are no reports of severe disease. (cdc.gov)
  • Soper added that disease state-dependent risk assessment also can apply to many other acute and chronic diseases beyond COVID-19, which have thus far largely been assessed only with static data and modeling techniques. (llnl.gov)
  • Patient experiences of the post-acute sequelae of coronavirus disease 2019 (COVID-19) or long COVID. (news-medical.net)
  • Kawasaki disease can be divided into three stages: acute, subacute and convalescent. (healthengine.com.au)
  • Other pertinent topics, such as risk in children, genetic susceptibility, and co-exposure to cadmium , are also considered. (cdc.gov)